Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that has no effective treatment. Nucleolin targeting by the pseudopeptide N6L inhibits the tumor growth and metastasis of pancreatic ductal adenocarcinoma (PDAC). Here, we explored the pathways regulated by nucleolin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Raineri, Fabio, Bourgoin-Voillard, Sandrine, Cossutta, Mélissande, Habert, Damien, Ponzo, Matteo, Houppe, Claire, Vallée, Benoît, Boniotto, Michele, Chalabi-Dchar, Mounira, Bouvet, Philippe, Couvelard, Anne, Cros, Jerome, Debesset, Anais, Cohen, José L., Courty, José, Cascone, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232280/
https://www.ncbi.nlm.nih.gov/pubmed/34203710
http://dx.doi.org/10.3390/cancers13122986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232280/
https://www.ncbi.nlm.nih.gov/pubmed/34203710
http://dx.doi.org/10.3390/cancers13122986

Ejemplares similares